Teva Pharmaceutical Industries Ltd TEVA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Teva Pharmaceuticals Gets FDA Approval for Bone Drug as Biosimilar
-
Teva Says FDA Accepts Ecopipam Application, Grants Priority Review
-
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis
-
Blackstone Gives Teva $400 Million to Develop Inflammatory Bowel Disease Treatment
-
Teva Pharmaceuticals Requests Removal of Some Patents From FDA Listing After FTC Warning
-
Alkermes Files Patent Litigation Against Teva, Apotex, MSN Pharmaceuticals
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 1.17B
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 15.96
- Price/Sales
- 2.57
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 32,842
- Website
- https://www.tevapharm.com
Competitors
Valuation
|
Metric
|
TEVA
|
VTRS
|
SDZ
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.96 | 6.93 | 40.24 |
Price/Book Value | 6.12 | 1.41 | 4.07 |
Price/Sales | 2.57 | 1.38 | 3.23 |
Price/Cash Flow | 14.77 | 7.11 | 33.28 |
Price/Earnings
TEVA
VTRS
SDZ
Financial Strength
|
Metric
|
TEVA
|
VTRS
|
SDZ
|
|---|---|---|---|
Quick Ratio | 0.46 | 0.82 | 0.50 |
Current Ratio | 0.88 | 1.58 | 1.05 |
Interest Coverage | 1.79 | −0.38 | 4.66 |
Quick Ratio
TEVA
VTRS
SDZ
Profitability
|
Metric
|
TEVA
|
VTRS
|
SDZ
|
|---|---|---|---|
Return on Assets (Normalized) | 6.68% | 7.94% | 7.69% |
Return on Equity (Normalized) | 35.32% | 19.79% | 18.79% |
Return on Invested Capital (Normalized) | 14.43% | 11.04% | 12.29% |
Return on Assets
TEVA
VTRS
SDZ
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|RNc>L&lJ | LOCK|Q$qfd | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|m<^h>Y$r | LOCK|c!Hy | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|hWTTwTz | LOCK|g>D | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|^j^d%&@> | LOCK|%Q | $29B | |||
| Viatris Inc
VTRS
| LOCK|Wm^$$!# | LOCK|?? | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|!@v | LOCK|^X | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|^tqpR<q | LOCK|?>q | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|&nK@$^ | LOCK|jVb | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|H%c^g#^ | LOCK|v#v%s | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|$XCt<t | LOCK|?Tp | $2B |
United States